Joint Venture Announcement

Click image to read

COVID-19: Challenging Times

Update 11/2020:

Global supply disruption due to COVID-19 continues to stagnate supply chain manufacturing capacity.

Various products of the TriCellPRP family are currently experiencing long supply fulfillment periods (up to 16 weeks). Please maintain tight oversight and purchase planning control of your local inventory supply.

REV-MED recognizes this major inconvenience and is working diligently with manufacturing to improve the situation.

/in  /by 

New ISO- and CE Certificates

REV-MED is proud to announce that we now have received new CE Certification for TriCellPRP and EN ISO 13845:2016 certification for the full quality management system. REV-MED changed the notified body and is now accredited with TÜV Süd Product Services GmbH from Munich, Germany.